Renaissance Technologies LLC Sells 21,611 Shares of Guardian Pharmacy Services, Inc. $GRDN

Renaissance Technologies LLC reduced its position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN) by 17.8% in the 1st quarter, Holdings Channel reports. The firm owned 99,989 shares of the company’s stock after selling 21,611 shares during the period. Renaissance Technologies LLC’s holdings in Guardian Pharmacy Services were worth $3,766,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Ameritas Investment Partners Inc. lifted its holdings in shares of Guardian Pharmacy Services by 26.5% in the third quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock worth $43,000 after acquiring an additional 345 shares during the last quarter. California State Teachers Retirement System grew its holdings in shares of Guardian Pharmacy Services by 3.4% during the 4th quarter. California State Teachers Retirement System now owns 17,983 shares of the company’s stock valued at $541,000 after purchasing an additional 593 shares during the last quarter. Police & Firemen s Retirement System of New Jersey increased its position in Guardian Pharmacy Services by 20.4% during the 4th quarter. Police & Firemen s Retirement System of New Jersey now owns 6,070 shares of the company’s stock worth $183,000 after purchasing an additional 1,028 shares in the last quarter. Price T Rowe Associates Inc. MD increased its position in Guardian Pharmacy Services by 13.4% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 11,885 shares of the company’s stock worth $358,000 after purchasing an additional 1,409 shares in the last quarter. Finally, Clearstead Advisors LLC lifted its stake in Guardian Pharmacy Services by 196.3% in the 4th quarter. Clearstead Advisors LLC now owns 2,628 shares of the company’s stock valued at $79,000 after purchasing an additional 1,741 shares during the last quarter.

Analyst Ratings Changes

A number of research firms have weighed in on GRDN. Truist Financial boosted their target price on shares of Guardian Pharmacy Services from $43.00 to $47.00 and gave the stock a “buy” rating in a research note on Wednesday, June 17th. Weiss Ratings raised Guardian Pharmacy Services from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday. Zacks Research lowered Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a research report on Monday, May 11th. Bank of America upped their target price on Guardian Pharmacy Services from $42.00 to $47.00 and gave the stock a “buy” rating in a report on Wednesday, June 17th. Finally, Wall Street Zen downgraded Guardian Pharmacy Services from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Seven analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $43.83.

Guardian Pharmacy Services Stock Performance

GRDN stock opened at $43.35 on Friday. The company has a market capitalization of $2.16 billion, a P/E ratio of 42.09, a PEG ratio of 2.59 and a beta of 0.10. The company has a fifty day moving average price of $40.93 and a 200-day moving average price of $37.09. Guardian Pharmacy Services, Inc. has a 52-week low of $19.30 and a 52-week high of $47.02.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, topping the consensus estimate of $0.26 by $0.03. The company had revenue of $351.77 million for the quarter, compared to analysts’ expectations of $340.45 million. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 31.45%. As a group, sell-side analysts forecast that Guardian Pharmacy Services, Inc. will post 1.18 earnings per share for the current fiscal year.

About Guardian Pharmacy Services

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.